Oncotest offer Reinnervate’s 3D cell technology to clients
Oncology CRO, Oncotest GmbH, will incorporate a new 3D cell culture technology into its range of preclinical assay services.
Archives for January 8, 2013
WHO should buy more China-made drugs says SFDA
The World Health Organisation (WHO) should buy more drugs made in China according to the SFDA.
Lonza to double ADC capacity to address Visp challenge
Lonza plans to double ADC capacity at its facility in Visp, Switzerland by 2014 in a move that it says could create new jobs.
LGC buys into bioanalytical services sector
LGC says entry into bioanalytical services space through the acquisition of Quotient testing division is part of a wider expansion plan.